Nicole M Bedanova

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Replacement Therapy

Induced Pluripotent Stem Cells

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

S M Rafiqul Islam, Takuya Maeda, Naritaka Tamaoki, Meghan L Good, Rigel J Kishton, Biman C Paria, Zhiya Yu, Marta Bosch-Marce, Nicole M Bedanova, Chengyu Liu, Michael J Kruhlak, Nicholas P Restifo, Raul Vizcardo
Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells. Cancer research communications 3 (5) (2023)
S M Rafiqul Islam, Takuya Maeda, Naritaka Tamaoki, Meghan L Good, Rigel J Kishton, Biman C Paria, Zhiya Yu, Marta Bosch-Marce, Nicole M Bedanova, Chengyu Liu, Michael J Kruhlak, Nicholas P Restifo, Raul Vizcardo
Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells. Cancer research communications 3 (5) (2023)
S M Rafiqul Islam, Takuya Maeda, Naritaka Tamaoki, Meghan L Good, Rigel J Kishton, Biman C Paria, Zhiya Yu, Marta Bosch-Marce, Nicole M Bedanova, Chengyu Liu, Michael J Kruhlak, Nicholas P Restifo, Raul Vizcardo
Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells. Cancer research communications 3 (5) (2023)
S M Rafiqul Islam, Takuya Maeda, Naritaka Tamaoki, Meghan L Good, Rigel J Kishton, Biman C Paria, Zhiya Yu, Marta Bosch-Marce, Nicole M Bedanova, Chengyu Liu, Michael J Kruhlak, Nicholas P Restifo, Raul Vizcardo
Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells. Cancer research communications 3 (5) (2023)
S M Rafiqul Islam, Takuya Maeda, Naritaka Tamaoki, Meghan L Good, Rigel J Kishton, Biman C Paria, Zhiya Yu, Marta Bosch-Marce, Nicole M Bedanova, Chengyu Liu, Michael J Kruhlak, Nicholas P Restifo, Raul Vizcardo
Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells. Cancer research communications 3 (5) (2023)